Medostatin

Lovastatin, the active ingredient in Medostatin, is a HMG‑CoA reductase inhibitor presented as a tablet for oral use. It lowers elevated low‑density lipoprotein (LDL) cholesterol and is prescribed for patients with hypercholesterolemia to reduce cardiovascular risk. It is used for primary and secondary prevention of atherosclerotic disease in adults with high LDL.

GNH USA supplies Medostatin as a licensed, GDP‑compliant supplier serving hospitals, pharmacies and clinics worldwide. The company follows quality standards and provides reliable logistics for global distribution.

Lovastatin is a statin that lowers LDL cholesterol by inhibiting hepatic cholesterol synthesis.

Hypercholesterolemia: reduces LDL cholesterol levels to target goals. Primary prevention of cardiovascular disease: lowers the risk of first cardiovascular events in patients with elevated LDL. Secondary prevention of cardiovascular events: helps prevent recurrent heart attacks or strokes in patients with established disease. Familial hypercholesterolemia: improves lipid profile in genetically high‑cholesterol patients.

Common Side Effects: - Muscle aches or weakness - Abdominal discomfort or constipation - Nausea or dyspepsia - Headache - Elevated liver enzymes (transient) Serious or Rare Side Effects: - Rhabdomyolysis leading to renal impairment - Severe allergic reactions such as Stevens‑Johnson syndrome - Persistent elevation of hepatic transaminases - Myopathy with significant muscle breakdown - Acute renal failure secondary to muscle breakdown

Lovastatin requires careful monitoring and specific precautions before and during therapy.

Dose adjustment in renal impairment: reduce dose or avoid in severe renal dysfunction. Monitor liver enzymes: obtain baseline and periodic liver function tests. Avoid in pregnancy: contraindicated due to fetal toxicity. Caution with CYP3A4 inhibitors: increased plasma levels may occur. Assess for muscle symptoms: discontinue if unexplained muscle pain or weakness develops. Store at room temperature: keep in original container, protect from moisture and heat.

Lovastatin may interact with several medicines, requiring avoidance or close monitoring.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin) - Gemfibrozil - High‑dose niacin - Protease inhibitors (e.g., ritonavir) - Certain antiretroviral agents

Moderate Interactions (Monitor Closely): - Amiodarone - Digoxin - Warfarin - Cyclosporine - Moderate CYP3A4 inhibitors (e.g., erythromycin)